Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease. ...
Apr 26, 2024
0
0
A new study led by researchers at the American Cancer Society (ACS) showed people surviving cancer who reported feeling more lonely experienced a higher mortality risk compared to survivors reporting low or no loneliness.
Apr 25, 2024
0
0
Doctoral candidate David Versluis successfully simulated an infant gut. This is crucial for research on improvements in formula milk. Currently, such research primarily relies on diaper contents, which is not optimal. Versluis ...
Apr 25, 2024
0
0
Investigators in the Smidt Heart Institute at Cedars-Sinai and colleagues report that women with type 2 diabetes diagnosed with hypertension before age 50 may benefit from intensive blood pressure treatment.
Apr 25, 2024
0
34
A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal of Clinical Oncology.
Apr 25, 2024
0
0
Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024, a scientific congress of the European Society of Cardiology ...
Apr 25, 2024
0
0
The suicide rate for men is about four times higher than for women. While men make up 50% of the population, they account for 80% of the suicides. Yet, suicide risk in men often goes unnoticed.
Apr 24, 2024
0
44
Blood sugar levels improve when adults with type 1 diabetes use modern insulin pumps. These are the findings of a study conducted at the University of Gothenburg. Patients are also overwhelmingly positive about the treatment.
Apr 24, 2024
0
0
A UC Davis Health study reveals persistent racial and social disparities preventing access to autoHCT, a common bone marrow transplant treatment to halt the progression of multiple myeloma.
Apr 23, 2024
0
0
Researchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife.
Apr 23, 2024
0
25
